Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amir Reza Eghtedari

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Prostaglandins & Other Lipid Mediators|May 16, 2022
Functional and pathological role of 15-Lipoxygenase and its metabolites in pregnancy and pregnancy-associated complicationsAmir Reza Eghtedari, Banafsheh Safizadeh, Mohammad Amin Vaezi, et al.
European Journal of Pharmacology|October 25, 2024
AI-Based solutions for current challenges in regenerative medicinePedram Asadi Sarabi, Mahshid Shabanpouremam, Amir Reza Eghtedari, et al.
BMC Musculoskeletal Disorders|August 3, 2022
Evaluation of the expression pattern and diagnostic value of PPARγ in malignant and benign primary bone tumorsAmir Reza Eghtedari, Mohammad Amin Vaezi, Banafsheh Safizadeh, et al.
Lipids in Health and Disease|November 28, 2021
15-Lipoxygenase and its metabolites in the pathogenesis of breast cancer: A double-edged swordMohammad Amin Vaezi, Banafsheh Safizadeh, Amir Reza Eghtedari, et al.
BMC Musculoskeletal Disorders|July 25, 2023
The clinical significance of CD44v6 in malignant and benign primary bone tumorsAmeinh Hosseini, Amir Reza Eghtedari, Alireza Mirzaei, et al.
Molecular Biology Reports|August 24, 2022
Up-regulation of matrix metalloproteinase-9 in primary bone tumors and its association with tumor aggressivenessMohammad Amin Vaezi, Amir Reza Eghtedari, Banafsheh Safizadeh, et al.
Frontiers in Oncology|January 30, 2023
Evaluating the local expression pattern of IGF-1R in tumor tissues and the circulating levels of IGF-1, IGFBP-1, and IGFBP-3 in the blood of patients with different primary bone tumorsMohammad Amin Vaezi, Amir Reza Eghtedari, Banafsheh Safizadeh, et al.
Scientific Reports|November 22, 2023
The expression changes of PD-L1 and immune response mediators are related to the severity of primary bone tumorsAmir Reza Eghtedari, Mohammad Amin Vaezi, Elaheh Safari, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Prostaglandins & Other Lipid Mediators|May 16, 2022
Functional and pathological role of 15-Lipoxygenase and its metabolites in pregnancy and pregnancy-associated complicationsAmir Reza Eghtedari, Banafsheh Safizadeh, Mohammad Amin Vaezi, et al.
European Journal of Pharmacology|October 25, 2024
AI-Based solutions for current challenges in regenerative medicinePedram Asadi Sarabi, Mahshid Shabanpouremam, Amir Reza Eghtedari, et al.
BMC Musculoskeletal Disorders|August 3, 2022
Evaluation of the expression pattern and diagnostic value of PPARγ in malignant and benign primary bone tumorsAmir Reza Eghtedari, Mohammad Amin Vaezi, Banafsheh Safizadeh, et al.
Lipids in Health and Disease|November 28, 2021
15-Lipoxygenase and its metabolites in the pathogenesis of breast cancer: A double-edged swordMohammad Amin Vaezi, Banafsheh Safizadeh, Amir Reza Eghtedari, et al.
BMC Musculoskeletal Disorders|July 25, 2023
The clinical significance of CD44v6 in malignant and benign primary bone tumorsAmeinh Hosseini, Amir Reza Eghtedari, Alireza Mirzaei, et al.
Molecular Biology Reports|August 24, 2022
Up-regulation of matrix metalloproteinase-9 in primary bone tumors and its association with tumor aggressivenessMohammad Amin Vaezi, Amir Reza Eghtedari, Banafsheh Safizadeh, et al.
Frontiers in Oncology|January 30, 2023
Evaluating the local expression pattern of IGF-1R in tumor tissues and the circulating levels of IGF-1, IGFBP-1, and IGFBP-3 in the blood of patients with different primary bone tumorsMohammad Amin Vaezi, Amir Reza Eghtedari, Banafsheh Safizadeh, et al.
Scientific Reports|November 22, 2023
The expression changes of PD-L1 and immune response mediators are related to the severity of primary bone tumorsAmir Reza Eghtedari, Mohammad Amin Vaezi, Elaheh Safari, et al.
Pageof 1